Medicine
Furosemide 40 mg/4 mL injection
Furosemide 40 mg/4 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Furosemide
- Brand
- Sold under the generic name
- Strength
- 40 mg/4 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials of 4 mL, 25 vials of 4 mL, 5 vials of 4 mL and 19 more
- Manufacturers
- Gland PharmaIndiaAccord HealthcareIndiaEugiaIndiaMicro LabsIndiaHealthFirstCardinal HealthFresenius KabiHospiraSagent PharmaceuticalsAmneal Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CA01 Furosemide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 July 2000
- Identifiers
- RxCUI 1719286, 1719290, 1719291 +2DailyMed set ID 39fd32f2-6bb7-4a65-d298-e48d26bc80c7, 644704c0-e6a5-4804-bfa6-795c8f83aa7a, 6d9caaab-d874-4cf1-b9fe-408452a18998 +17NDC 0409-6102, 68083-433, 72572-275 +15Application NDA018667, ANDA213902, NDA018267 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 16729-501-43 | Accord HealthcareIndia | 21 April 2021 |
| 25 vial in 1 carton / 4 mL in 1 vial | 55150-323-25 | EugiaIndia | 3 May 2019 |
| 5 vial, glass in 1 box / 4 mL in 1 vial, glass | 68083-433-05 | Gland PharmaIndia | 1 July 2020 |
| 25 vial, glass in 1 box / 4 mL in 1 vial, glass | 68083-433-25 | Gland PharmaIndia | 1 July 2020 |
| 25 vial in 1 carton / 4 mL in 1 vial | 42571-437-66 | Micro LabsIndia | 1 March 2026 |
| 25 vial in 1 tray / 4 mL in 1 vial | 63323-280-04 | Fresenius Kabi | 12 July 2000 |
| 25 vial in 1 tray / 4 mL in 1 vial | 63323-280-26 | Fresenius Kabi | 12 July 2000 |
| 25 vial, single-dose in 1 tray / 4 mL in 1 vial, single-dose | 0409-6102-04 | Hospira | 28 February 2005 |
| 25 vial, single-dose in 1 tray / 4 mL in 1 vial, single-dose | 0409-6102-26 | Hospira | 19 November 2013 |
| 25 vial in 1 carton / 4 mL in 1 vial | 25021-311-04 | Sagent Pharmaceuticals | 15 March 2021 |
| 25 vial in 1 carton / 4 mL in 1 vial | 25021-320-04 | Sagent Pharmaceuticals | 15 July 2025 |
| 25 vial, glass in 1 carton / 4 mL in 1 vial, glass | 70121-1164-5 | Amneal Pharmaceuticals | 25 July 2016 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 0143-9156-10 | Hikma Pharmaceuticals | 19 August 2024 |
| 25 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 71288-203-05 | Meitheal Pharmaceuticals | 27 January 2022 |
| 5 vial, single-use in 1 bag / 4 mL in 1 vial, single-use | 55154-2365-5 | Cardinal Health | 28 February 2005 |
| 5 vial in 1 bag / 4 mL in 1 vial | 55154-9582-5 | Cardinal Health | 12 July 2000 |
| 4 mL in 1 vial, single-use | 51662-1336-1 | HealthFirst | 26 November 2018 |
| 4 mL in 1 vial | 51662-1574-1 | HealthFirst | 28 June 2021 |
| 25 pouch in 1 case / 1 vial in 1 pouch / 4 mL in 1 vial | 51662-1574-3 | HealthFirst | 28 June 2021 |
| 25 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 83634-302-04 | Avenacy | 15 March 2024 |
| 10 vial, single-dose in 1 carton / 4 mL in 1 vial, single-dose | 72572-275-10 | Civica | 13 July 2026 |
| 1 vial, single-dose in 1 bag / 4 mL in 1 vial, single-dose | 71872-7278-1 | Medical Purchasing Solutions | 10 January 2022 |
| 25 vial in 1 carton / 4 mL in 1 vial | 23155-473-42 | — | 2 September 2014 |
| 50 vial in 1 carton / 4 mL in 1 vial | 23155-473-43 | — | 2 September 2014 |
| 25 vial, glass in 1 box / 4 mL in 1 vial, glass | 31722-310-32 | — | 13 December 2024 |
| 5 vial in 1 carton / 4 mL in 1 vial | 70756-619-05 | — | 17 December 2022 |
| 10 vial in 1 carton / 4 mL in 1 vial | 70756-619-10 | — | 17 December 2022 |
| 25 vial in 1 carton / 4 mL in 1 vial | 70756-619-25 | — | 17 December 2022 |
| 25 vial in 1 carton / 4 mL in 1 vial | 73542-102-25 | — | 16 June 2025 |
| 5 vial, single-dose in 1 box / 4 mL in 1 vial, single-dose | 36000-064-05 | — | 6 February 2014 |
| 25 vial, single-dose in 1 box / 4 mL in 1 vial, single-dose | 36000-283-25 | — | 6 February 2014 |
| 25 vial, glass in 1 box / 4 mL in 1 vial, glass | 73043-023-01 | — | 10 August 2024 |
| 1 vial, glass in 1 bag / 4 mL in 1 vial, glass | 71872-7127-1 | — | 30 March 2018 |
| 1 vial in 1 bag / 4 mL in 1 vial | 71872-7314-1 | — | 6 October 2023 |
| 5 vial, single-dose in 1 bag / 4 mL in 1 vial, single-dose | 55154-4452-5 | — | 6 February 2014 |
| 25 vial, single-dose in 1 box / 4 mL in 1 vial, single-dose | 72572-190-25 | — | 23 September 2022 |
| 25 pouch in 1 box / 1 vial, glass in 1 pouch / 4 mL in 1 vial, glass | 51662-1719-3 | — | 13 December 2024 |
| 1 vial, single-dose in 1 bag / 4 mL in 1 vial, single-dose | 0404-9863-04 | — | 10 January 2022 |
| 25 vial in 1 carton / 4 mL in 1 vial | 72603-251-25 | — | 1 February 2023 |
| 25 vial in 1 carton / 4 mL in 1 vial | 72603-251-25 | — | 15 July 2025 |
| 4 mL in 1 vial | 84549-251-25 | — | 27 August 2025 |
| 25 vial, glass in 1 box / 4 mL in 1 vial, glass | 70518-4444-0 | — | 15 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Furosemide 40 mg/4 mL injection.
Other strengths and forms of Furosemide
Clinical summary
Furosemide is a loop diuretic indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. MedsAcross supplies Furosemide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FurosemideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lasix prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Bopediat: European public assessment report (EPAR) · European Medicines Agency
Need Furosemide 40 mg/4 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.